Kratom industry distinguishes natural leaf from synthetic opioids in Ole Miss deaths

Two college students at Ole Miss were found dead on September 21, each at a separate location. Aidan Hamilton was eighteen. Robert Strang was twenty. Near both bodies, investigators recovered packaging associated with kratom-related products—specifically items bearing the brand name Modus, labeled as Smax Pseudo-DHM tablets, with ingredients listed as pseudoindoxyl and MGM-15(DHM). Toxicology results remain pending, but the initial characterization of these products as kratom has become a point of sharp dispute.

The American Kratom Association moved quickly to challenge how the deaths were being framed. Mac Haddow, the organization's senior fellow on public policy, told Fox News Digital that calling these products kratom was misleading and potentially dangerous to public understanding. He noted it would be statistically improbable for natural kratom leaf to cause even one death, let alone two independent fatalities. After contacting Oxford police, the association held a press conference in the city demanding clarification. The result: investigators acknowledged that the products recovered were not natural kratom at all, but chemically manipulated opioids—controlled substances under federal law that should never have been sold in the first place.

The distinction matters because it shapes how we understand both the tragedy and the regulatory landscape. Natural kratom, according to Haddow, is a leaf product used for centuries in Southeast Asia with no published record of deaths linked to traditional use, though medical literature does document some adverse effects from long-term consumption. The story of how kratom entered the United States—brought back by Vietnam War veterans and Southeast Asian immigrants—remains unsubstantiated in peer-reviewed research, but the industry's account is that amateur chemists then began altering the plant's alkaloid composition, adulterating it in ways that triggered FDA and DEA attention. In 2012, the FDA issued an import alert on kratom products. Four years later, the DEA sought to classify kratom's primary alkaloids as Schedule I substances before withdrawing that proposal after public comment.

What distinguishes the products found near the Ole Miss students is their chemical manipulation. Haddow described the process: chemists extract and concentrate alkaloids, rearrange molecules, and synthesize them using high-concentration chlorine, baking soda, and other methods to produce what amounts to a signature opioid effect. The specific compounds in question—7-hydroxymitragynine (7-OH), Sudendoxyl, MGM-15, and MGM-16—should be classified as synthetic opioids, not kratom, he argued. The analogy he offered was direct: if someone extracted caffeine from coffee, concentrated it to lethal levels, and a person died from ingesting it, we would blame the person who manipulated the substance, not coffee itself.

Mississippi has a Kratom Consumer Protection Act on the books, a state law that regulates rather than bans the product. It establishes standards for sellers, permitted products, and labeling requirements while prohibiting adulterated or high-potency versions. Haddow questioned why these regulations were not being enforced at the point of sale. The association's position is that the answer lies not in banning kratom but in strengthening enforcement and establishing clearer distinctions between natural and synthetic variants.

The organization is now pushing for regulations that require testing, labeling, and age restrictions—twenty-one and older access only. Haddow emphasized that natural kratom, in his view, is helping people with health and wellness and potentially saving lives. He cited an NIH-led study moving forward to evaluate whether purified mitragynine, the main alkaloid in the kratom plant, could help treat opioid use disorder. The FDA, for its part, maintains that kratom has not been approved for any medical use and has warned of risks including dependence, contamination, and adverse events. Researchers continue studying both the plant and its individual compounds.

The pending toxicology results will provide the definitive answer about what killed these two students. But the framing battle is already underway—whether the public will understand these deaths as evidence against natural kratom or as evidence of a regulatory failure to prevent dangerous synthetic opioids from reaching consumers.